EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer

Tina Toft Kristensen iD, Christina Caroline Plaschke, Anne Fog Lomholt, Christoffer Holst Hahn, Irene Wessel, Mads Aage Toft Kristensen, Jens Bentzen, Christina Ellervik

European Thyroid Journal · 2025

DOI: 10.1530/etj-24-0282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, 2025. Verfasst von Tina Toft Kristensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy, Thyroid Gland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for low-risk differentiated thyroid cancer if a postoperative thyroid-stimulating hormone increase up to 4 mIU/L is accepted.

Method

A retrospective review of a total of 162 Eastern Danish patients was conducted. Patients were initially followed up without levothyroxine treatment after hemithyroidectomy for differentiated thyroid cancer if thyroid-stimulating hormone was below 4 mIU/L, in accordance with the Danish treatment guideline. Patients’ hospital charts were reviewed, and data on the initiation of levothyroxine treatment, pre- and postoperative thyroid-stimulating hormone, recurrence, and remnant lobe nodularity were collected.

Results

A total of 143/162 (88%) did not take levothyroxine before hemithyroidectomy, with a median (interquartile range) age of 53 (43–65) years; 80% were women. During follow-up, the prevalence of endogenous normal thyroid function gradually decreased to 80, 69, and 66% after 1, 2, and 3 years. Concomitantly, hypothyroidism developed with thyroid-stimulating hormone >4.0 mIU/L in 20, 31, and 34% of patients, who were replaced with levothyroxine. In patients not on levothyroxine, TSH was significantly increased within the normal range 1, 2, and 3 years after hemithyroidectomy for DTC ( P < 0.0001). 4/143 (3%) had completion thyroidectomies due to growth of preexisting nodules; no patient had a recurrence.

Conclusion

One-third of differentiated thyroid cancer patients require levothyroxine treatment 3 years after hemithyroidectomy if postoperative thyroid-stimulating hormone levels up to 4 mIU/L are accepted. Avoidance of levothyroxine treatment happens at the expense of a significant increase in thyroid-stimulating hormone levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroidectomyThyroid GlandHumansFemaleMiddle AgedMaleRetrospective StudiesThyrotropinAdultThyroxineAgedHypothyroidismPrevalenceThyroid Function TestsDenmark

Stichwörter der Autor:innen

differentiated thyroid cancerhemithyroidectomypostoperative LT4 treatmentthyroid function

Substanzen

ThyrotropinThyroxine

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Department of Oncology, Herlev Hospital, Herlev, Denmark.
  • University of Copenhagen, Copenhagen, Denmark.
  • Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, USA.

ORCID-Profile: Tina Toft Kristensen

Zitieren

APA

Toft Kristensen, T., Plaschke, C. C., Fog Lomholt, A., Holst Hahn, C., Wessel, I., Toft Kristensen, M. A., Bentzen, J., & Ellervik, C. (2025). Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer. European Thyroid Journal. https://doi.org/10.1530/etj-24-0282

Vancouver

Toft Kristensen T, Plaschke CC, Fog Lomholt A, Holst Hahn C, Wessel I, Toft Kristensen MA, et al. Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer. European Thyroid Journal. 2025. doi:10.1530/etj-24-0282

BibTeX
@article{ToftKristensen2025,
  author = {Toft Kristensen, Tina and Plaschke, Christina Caroline and Fog Lomholt, Anne and Holst Hahn, Christoffer and Wessel, Irene and Toft Kristensen, Mads Aage and Bentzen, Jens and Ellervik, Christina},
  title = {Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer},
  journal = {European Thyroid Journal},
  year = {2025},
  doi = {10.1530/etj-24-0282}
}
Kostenlos starten →